CCI250117C100000
- 0.10
- -0.05-33.33%
Crown Castle Newsroom
Analysts' Opinions Are Mixed on These Real Estate Stocks: Crown Castle (CCI) and Healthpeak Properties (DOC)
Barclays Maintains Crown Castle(CCI.US) With Hold Rating, Maintains Target Price $117
BMO Capital Cuts Price Target on Crown Castle to $106 From $115, Keeps Market Perform Rating
Goldman Sachs Adjusts Crown Castle Price Target to $116 From $120, Maintains Neutral Rating
Crown Castle Cut to Underweight From Equal-Weight by Wells Fargo
Crown Castle Analyst Ratings
Wells Fargo Downgrades Crown Castle(CCI.US) to Sell Rating, Maintains Target Price $100
Barclays Downgrades Crown Castle(CCI.US) to Hold Rating, Cuts Target Price to $117
Crown Castle Is Maintained at Equal-Weight by Barclays
Barclays Maintains Crown Castle(CCI.US) With Hold Rating, Raises Target Price to $117
Crown Castle Analyst Ratings
RBC Capital Maintains Crown Castle(CCI.US) With Hold Rating, Raises Target Price to $109
Analysts Offer Insights on Real Estate Companies: First Industrial Realty (FR), Crown Castle (CCI) and Weyerhaeuser (WY)
Deutsche Bank Adjusts Price Target on Crown Castle to $116 From $115
BMO Capital Maintains Crown Castle(CCI.US) With Hold Rating, Raises Target Price to $115
BofA Securities Maintains Crown Castle(CCI.US) With Hold Rating, Maintains Target Price $115
Crown Castle Price Target Raised to $105.00/Share From $100.00 by Wells Fargo
Crown Castle Is Maintained at Equal-Weight by Wells Fargo
J.P. Morgan Maintains Crown Castle(CCI.US) With Hold Rating, Cuts Target Price to $121
A Quick Look at Today's Ratings for Crown Castle(CCI.US), With a Forecast Between $115 to $128